Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors. Authors' reply.
Carlos TaxoneraIñigo SagastagoitiaCristina AlbaNorberto MañasDavid OlivaresEnrique ReyPublished in: Alimentary pharmacology & therapeutics (2020)